Pilot study demonstrating changes in DNA hydroxymethylation enable detection of multiple cancers in plasma cell-free DNA

Anna Bergamaschi, Yuhong Ning, Chin-Jen Ku, Chris Ellison, Francois Collin, Gulfem Guler, Tierney Phillips, Erin McCarthy, Wendy Wang, Michael Antoine, Aaron Scott, Paul Lloyd, Alan Ashworth, Steve Quake, Samuel Levy
doi: https://doi.org/10.1101/2020.01.22.20018382

Article Information

doi 
https://doi.org/10.1101/2020.01.22.20018382
History 
  • January 27, 2020.
Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.

Author Information

  1. Anna Bergamaschi1,
  2. Yuhong Ning1,
  3. Chin-Jen Ku1,
  4. Chris Ellison1,
  5. Francois Collin1,
  6. Gulfem Guler1,
  7. Tierney Phillips1,
  8. Erin McCarthy1,
  9. Wendy Wang1,
  10. Michael Antoine1,
  11. Aaron Scott1,
  12. Paul Lloyd1,
  13. Alan Ashworth2,
  14. Steve Quake3 and
  15. Samuel Levy1,*
  1. 1Bluestar genomics, San Diego, CA
  2. 2UCSF Helen Diller Family Comprehensive Cancer Cent, San Francisco, CA
  3. 3Stanford University, Palo Alto, CA
  1. ↵*Corresponding author; email: slevy{at}bluestargenomics.com
Back to top
Posted January 27, 2020.
Download PDF
Data/Code
Email
Pilot study demonstrating changes in DNA hydroxymethylation enable detection of multiple cancers in plasma cell-free DNA
Anna Bergamaschi, Yuhong Ning, Chin-Jen Ku, Chris Ellison, Francois Collin, Gulfem Guler, Tierney Phillips, Erin McCarthy, Wendy Wang, Michael Antoine, Aaron Scott, Paul Lloyd, Alan Ashworth, Steve Quake, Samuel Levy
medRxiv 2020.01.22.20018382; doi: https://doi.org/10.1101/2020.01.22.20018382
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area